In addition, the reduced TUSC2 mRNA levels were significantly associated with advanced tumor stages (p < 0.0001), the presence of lymph node metastasis (p < 0.0001), and a poorer histological differentiation (p < 0.05, Figure 5H). Here, TUSC2 is linked to neoplasm.